Moderna stock rally fades as analysts weigh in on what U.S. government supply deal means for COVID-19 vaccine pricing

The rally in Moderna Inc. shares sparked by news late Tuesday that the U.S. government has ordered 100 million doses of its COVID-19 vaccine candidate dissipated on Wednesday, as analysts weighed in on what the order means for pricing.